홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Succinylcholine Chloride

HCID 22475
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
71-27-2
표준 SMILES
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]
InChIKey
YOEWQQVKRJEPAE-UHFFFAOYSA-L
분자식
C14H30N2O4.2Cl
평균 분자량
361.3 g/mol
단동위원소 질량
360.1582628

개요

Suxamethonium dichloride is a fine white powder. (NTP, 1992)

이름 및 식별자

우선 이름
Succinylcholine Chloride
IUPAC
trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium dichloride
영어명
Succinylcholine Chloride
분자식
C14H30Cl2N2O4
분자량
361.3

이름 및 동의어

Succinylcholine chloride71-27-2Succinyldicholine chlorideAnectineMidarineScolineAnectine chlorideSuxamethonii chloridumLysthenoneMyopleginePantolaxSucostrin
이름 더 보기
SUXAMETHONIUM CHLORIDEDITILINskolinLYSTHENONSUCCICURAN
SukolinSuxinylSuccinyl-astaScoline chlorideCloruro de suxametonioQuelicin chlorideSucostrin chlorideChlorsuccinylcholin

데이터베이스 식별자

CAS
71-27-2
PubChem CID
22475
DTXSID
DTXSID1023603
ChEMBL
CHEMBL983
ChEBI
CHEBI:61219
UNII
I9L0DDD30I
EC Number
200-747-4

물성

구조 계산 물성

극성 표면적
52.6 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
6
회전 가능 결합 수
11
무거운 원자 수
22
형식 전하
0
복잡도
284

실험 및 물리화학적 성질

Solubilitygreater than or equal to 100 mg/mL at 68 °F (NTP, 1992)
Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point313 to 325 °F (NTP, 1992)
Physical DescriptionSuxamethonium dichloride is a fine white powder. (NTP, 1992)

물리화학적 성질

녹는점
164 °C · 164 °C
저장 조건
Refrigerator
용해도
메탄올(약간 용해됨), 물(약간 용해됨)
물리적 상태
고체
색상
흰색에서 황백색까지
Merck
8875 · 8875
안정성
안정적인. 타기 쉬운. 강한 산화제와 호환되지 않습니다.
EPA
Succinylcholine chloride (71-27-2)
화학적 성질 · 1건

Succinylcholine chloride is a white, odorless, slightly bitter powder and very soluble in water. The drug is unstable in alkaline solutions but relatively stable in acid solutions, depending upon the concentration of the solution and the storage temperature. Solutions of succinylcholine chloride should be stored under refrigeration to preserve potency.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (93.1%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 29 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Other Safety InformationIMAP assessments - Ethanaminium, 2,2'-[(1,4-dioxo-1,4-butanediyl)bis(oxy)]bis[N,N,N-trimethyl-, dichloride: Environment tier I assessment
DOT LabelPoison
Fire HazardsFlash point data for this chemical are not available. It is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Symptoms of exposure to this compound may include relaxation of skeletal muscles, particularly those of the abdominal wall.
Reactive GroupEsters, Sulfate Esters, Phosphate Esters, Thiophosphate Esters, and Borate Esters
Air and Water ReactionsWater soluble.
Hazard Classes and CategoriesAcute Tox. 3 (93.1%)

안전 및 보호

Fire Fighting

화학 및 산업

약리 정보

FDA Pharmacological Classification · 2건

SUCCINYLCHOLINE CHLORIDE

Depolarizing Neuromuscular Blocker [EPC]; Neuromuscular Depolarizing Blockade [PE]

MeSH Pharmacological ClassificationDrugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.
응용 분야 · 3건

개요Succinylcholine chloride is a potent relaxant of voluntary striated muscle but has little direct effect on smooth muscle. It has no anesthetic or pain-obliterating properties; therefore, immobilized animals remain completely conscious although unable to move. The duration of effect is quite brief because succinylcholine is rapidly destroyed by non-specific cholinesterases in the blood plasma and liver. Immobilization lasts five to 12 minutes in man and horses and somewhat longer in other species,with ruminants generally requiring longest recovery periods (Stowe et al. 1958).Since the discovery of its curariform properties in 1949, succinylcholine has been widely used for immobilization of animals and in human surgical procedures. Several workers have used succinylcholine on bears (Black 1958, Knudsen 1959, Craighead et al. 1960, Troyer et al. 1961,Hornocker 1962, Mundy 1963,Pearson et al. 1968, Jonkel and Cowan 1971 and Mundy and Flook 1973).Succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

용도A neuromuscular blocking agent. Muscle relaxant (skeletal).

일반 설명Succinylcholine chloride,choline chloride succinate (2:1) (Anectine, Sucostrin),is a white, odorless, crystalline substance that is freely solublein water to give solutions with a pH of about 4. It isstable in acidic solutions but unstable in alkali. Aqueous solutionsshould be refrigerated to ensure stability.Succinylcholine chloride is characterized by a very shortduration of action and a quick recovery because of its rapidhydrolysis after injection. It brings about the typical muscularparalysis caused by blocking nervous transmission at themyoneural junction. Large doses may cause temporary respiratorydepression, as with similar agents. Its action, in contrastwith that of (1)-tubocurarine, is not antagonized byneostigmine, physostigmine, or edrophonium chloride.These anticholinesterase drugs actually prolong the action ofsuccinylcholine chloride, which suggests that the drug isprobably hydrolyzed by cholinesterases. The brief durationof action of this curare-like agent is said to render an antidoteunnecessary if the proper supportive measures are available.Succinylcholine chloride has a disadvantage, however, inthat the usual antidotes cannot terminate its action promptly.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1건

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1건

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Isolation and EvacuationExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1건

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)

독성 정보

Adverse Effects · 1건

Hyperkalemia is the most common adverse effect of succinylcholine administration, attributed to the drug's stimulatory effect on skeletal muscles. Serum potassium levels may increase as much as 0.5 mEq/L, which is clinically insignificant unless a predisposition to hyperkalemia exists as a result of disease pathophysiology that induces upregulation of postjunctional acetylcholine receptors. Succinylcholine is contraindicated for patients with these conditions. If hyperkalemia is sufficient to create electrocardiography changes, clinicians should avoid using succinylcholine in such circumstances. Special consideration is also necessary for those with chronically elevated potassium levels, such as renal failure patients, to not induce acute on chronic hyperkalemia. Succinylcholine should be avoided in patients with significant burns or traumatic injuries that are 24 to 72 hours post-injury due to the high probability of acute hyperkalemia that may become exacerbated as a result. Marked or untreated hyperkalemia may result in dysrhythmias or even death.

Toxicity SummarySigns and Symptoms of Overdose
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Succinylcholine chloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

안전 데이터

rtecs
GA2360000
ridadr
3249
독성
LD50 i.v. in mice: 0.45 mg/kg (Anttila, Ertama)
safety_code
7/8
포장분류
III
위험 등급
6.1(b)

상·하류 제품 정보

상류 원료

염화메틸수산화나트륨Butanedioic acid, 1,4-bis(2-nitrophenyl) esterButanedioic acid, 1,4-bis(4-nitrophenyl) esterButanedioic acid,1,4-bis(2-chloroethyl) ester비스[2-(디메틸아미노)에틸]숙시네이트

추가 설명

정의ChEBI: A chloride salt in which the negative charge of the chloride ions is balanced by succinylcholine dications.